Citation:Hugosson J, Carlsson S, Aus G, Bergdahl S, Khatami A, Lodding P, et al 2010

From Cancer Guidelines Wiki

Citation


Hugosson J, Carlsson S, Aus G, Bergdahl S, Khatami A, Lodding P, et al. Mortality results from the Göteborg randomised population-based prostate-cancer screening trial. Lancet Oncol 2010 Aug;11(8):725-32 Available from: http://www.ncbi.nlm.nih.gov/pubmed/20598634.


This is a publication of ERSPC

Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
For asymptomatic men without a prostate cancer diagnosis, what PSA testing strategies with or without DRE compared to no PSA testing or other PSA testing strategies reduce prostate cancer specific mortality or the incidence of metastases at diagnosis?Tracy Tsangcompleted
For asymptomatic men without a prostate cancer diagnosis, what PSA testing strategies with or without DRE compared to no PSA testing or other PSA testing strategies reduce prostate cancer specific mortality or the incidence of metastases at diagnosis?Suzanne Hughescompleted
For men without a prostate cancer diagnosis or symptoms that might indicate prostate cancer, how many years after the start of PSA testing is the benefit of PSA testing apparent?Tracy Tsangcompleted
For men without a prostate cancer diagnosis or symptoms that might indicate prostate cancer, how many years after the start of PSA testing is the benefit of PSA testing apparent?Suzanne Hughescompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:For asymptomatic men without a prostate cancer diagnosis, what PSA testing strategies with or without DRE compared to no PSA testing or other PSA testing strategies reduce prostate cancer specific mortality or the incidence of metastases at diagnosis?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:For asymptomatic men without a prostate cancer diagnosis, what PSA testing strategies with or without DRE compared to no PSA testing or other PSA testing strategies reduce prostate cancer specific mortality or the incidence of metastases at diagnosis?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:For asymptomatic men without a prostate cancer diagnosis, what PSA testing strategies with or without DRE compared to no PSA testing or other PSA testing strategies reduce prostate cancer specific mortality or the incidence of metastases at diagnosis?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:For asymptomatic men without a prostate cancer diagnosis, what PSA testing strategies with or without DRE compared to no PSA testing or other PSA testing strategies reduce prostate cancer specific mortality or the incidence of metastases at diagnosis?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:For men without a prostate cancer diagnosis or symptoms that might indicate prostate cancer, how many years after the start of PSA testing is the benefit of PSA testing apparent?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:For men without a prostate cancer diagnosis or symptoms that might indicate prostate cancer, how many years after the start of PSA testing is the benefit of PSA testing apparent?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:For men without a prostate cancer diagnosis or symptoms that might indicate prostate cancer, how many years after the start of PSA testing is the benefit of PSA testing apparent?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:For men without a prostate cancer diagnosis or symptoms that might indicate prostate cancer, how many years after the start of PSA testing is the benefit of PSA testing apparent?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. Discussion
  2. ERSPC
  3. Introduction
  4. PSA Testing strategies
  5. PSA testing and life expectancy